The Cognitive Penalty of ECT Has Always Been Its Ceiling — MST Just Removed It
CREST–MST in Lancet Psychiatry shows magnetic seizure therapy matches ECT remission rates with superior cognitive safety—reshaping convulsive therapy trial…
AI in Clinical Trials
EU Clinical Trials Face Cost, Speed, and China Competition Pressure
At the Clinical Trial Innovation Summit 2025 in Basel, industry leaders from UCB, Novo Nordisk, Novartis, and Medable debated...
How LLMs Can Audit LSD Clinical Trial Ratings in Real Time
MindMed is running three phase three trials of pharmaceutically optimized LSD with a two-person AI team and a custom...
AI Platform Predicts Clinical Trial Outcomes with High Accuracy
At the Clinical Trial Innovation Summit 2025 in Basel, QuantHealth's Chief Medical Officer presented AI-driven trial simulation technology capable...
MST Matches ECT Efficacy—and Leaves Memory Intact. The CREST-MST Trial Just Changed the Convulsive Therapy Conversation
The CREST-MST trial in Lancet Psychiatry shows magnetic seizure therapy matches ECT remission rates in TRD with a superior...
The MASAI Trial Just Made AI-Augmented Mammography the Standard of Care. The FDA Hasn’t Noticed
The MASAI trial showed AI-plus-one-radiologist outperforms two radiologists in breast cancer screening. FDA's AI device framework still treats this...
AI in Research: Key Takeaways from the EU AI Act
Artificial Intelligence (AI) is playing an increasingly significant role in scientific research and development (R&D), particularly within the biopharmaceutical...
Artificial Intelligence in Clinical Trials: How to Navigate the Promise and Perils
The pharmaceutical industry, a realm of precision, ethics, and high stakes, stands at the precipice of a digital transformation...